Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 20/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 20/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 8/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15580303 | 0.99 | HDAC3 (1.00) | HDAC3HDAC1HDAC6HDAC2HDAC8 | |
| SCHEMBL15580274 | 0.99 | HDAC3 (1.00) | HDAC3HDAC1HDAC6HDAC2HDAC8 | |
| SCHEMBL20691496 | 0.80 | HDAC3 (0.66) | HDAC3HDAC1HDAC6 | |
| SCHEMBL24780896 | 0.79 | HDAC3 (0.66) | HDAC3HDAC1HDAC6 | |
| SCHEMBL15580214 | 0.79 | HDAC3 (1.00) | HDAC3HDAC1HDAC6HDAC2HDAC8 | |
| SCHEMBL24780895 | 0.79 | HDAC3 (0.65) | HDAC3HDAC1HDAC6HDAC2HDAC8 | |
| SCHEMBL23164198 | 0.79 | HDAC1 (0.65) | HDAC3HDAC1HDAC6 | |
| SCHEMBL24781178 | 0.78 | HDAC3 (0.64) | HDAC3HDAC1HDAC6HDAC2HDAC8 | |
| SCHEMBL28944487 | 0.76 | HDAC3 (0.62) | HDAC3HDAC1HDAC6 | |
| SCHEMBL19114635 | 0.76 | HDAC3 (0.60) | HDAC3HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2708534-B1 | THIAZOLE COMPOUND AND PREPARATION METHOD AND USE THEREOF | SHANGHAI THEORION PHARMACEUTICAL CO LTD (CN) | 2017-07-12 | — | — | EP | disclosed |
| US-9216962-B2 | Thiazole compounds, methods for preparation and use thereof | SHANGHAI PUYI CHEMICAL CO., LTD. (CN) | 2015-12-22 | — | — | US | disclosed |
| US-20140148600-A1 | THIAZOLE COMPOUNDS, METHODS FOR PREPARATION AND USE THEREOF | SHANGHAI THEORION PHARMACEUTICAL CO., LTD. (CN) | 2014-05-29 | — | — | US | disclosed |
| EP-2708534-A1 | THIAZOLE COMPOUND AND PREPARATION METHOD AND USE THEREOF | Shanghai Puyi Chemical Co., Ltd. (CN) | 2014-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148600-A1 | THIAZOLE COMPOUNDS, METHODS FOR PREPARATION AND USE THEREOF | HDAC5, HDAC7, HDAC1 | HDAC3 9/4885HDAC1 3/4885HDAC6 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.